Friess Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-117,585
| Closed | -$13.1M | – | 152 |
|
|
2019
Q4 | $13.1M | Sell |
117,585
-4,150
| -3% | -$461K | 0.91% | 51 |
|
|
2019
Q3 | $12.1M | Buy |
121,735
+39,397
| +48% | +$3.91M | 0.93% | 54 |
|
|
2019
Q2 | $8.16M | Buy |
82,338
+2,436
| +3% | +$242K | 0.6% | 66 |
|
|
2019
Q1 | $8.81M | Buy |
79,902
+2,870
| +4% | +$317K | 0.65% | 59 |
|
|
2018
Q4 | $7.08M | Hold |
77,032
| – | – | 0.61% | 58 |
|
|
2018
Q3 | $8.49M | Sell |
77,032
-12
| -0% | -$1.32K | 0.59% | 59 |
|
|
2018
Q2 | $7.19M | Hold |
77,044
| – | – | 0.57% | 63 |
|
|
2018
Q1 | $6.39M | Buy |
77,044
+9,741
| +14% | +$808K | 0.52% | 71 |
|
|
2017
Q4 | $6.13M | Buy |
67,303
+1,654
| +3% | +$151K | 0.51% | 72 |
|
|
2017
Q3 | $5M | Buy |
65,649
+1,089
| +2% | +$82.9K | 0.44% | 71 |
|
|
2017
Q2 | $4.84M | Buy |
64,560
+6,260
| +11% | +$470K | 0.44% | 76 |
|
|
2017
Q1 | $3.8M | Buy |
+58,300
| New | +$3.8M | 0.36% | 75 |
|